Company Overview and News

 
NZ shares rise led by Synlait, A2, Comvita as US earnings stoke global sentiment

2018-04-19 nzherald.co.nz
New Zealand shares gained as the US earnings season helped lift sentiment toward equities. Growth-linked companies including Synlait Milk, A2 Milk, Comvita led gains in the local market.
Upvote Downvote

 
Shares rise on optimism US and China will avoid trade war

2018-04-09 nzherald.co.nz
New Zealand shares rose as the local bourse joined a region-wide rally on optimism the US and China will manage to avoid a trade war that could slow global growth. Sky Network Television, Fisher & Paykel Healthcare and Spark NZ led broad-based gains. Orion Health jumped 11 per cent.
Upvote Downvote

 
NZ shares up, Sky TV bounces with Comvita

2018-04-06 nzherald.co.nz
New Zealand shares gained, led by Sky Network Television bouncing back and Orion Health surging 20 per cent after it confirmed it's considering sale options.
Upvote Downvote

 
A2 Milk bounces in mixed day for New Zealand sharemarket

2018-04-03 nzherald.co.nz
New Zealand shares were mixed, with A2 Milk Co bouncing after recent selling while Orion Health Group sank to a record low.
Upvote Downvote

 
MARKET CLOSE: NZ shares rise; Metro Glass rebounds ahead of index exit, Comvita falls

2018-03-09 nbr.co.nz
New Zealand shares rose, led higher by a rebounding Metro Performance Glass. Spark New Zealand gained while Comvita fell.
Upvote Downvote

 
NZ shares rise; Spark gains

2018-03-09 nzherald.co.nz
New Zealand shares rose, led higher by a rebounding Metro Performance Glass. Spark New Zealand gained while Comvita fell.
Upvote Downvote

 
Trade Me Group acquisition approval declined by Commerce Commission

2018-03-08 proactiveinvestors.com.au
Trade Me Group Ltd (ASX:TME) (NZE:TME) has had its conditional acquisition of Motorcentral (Limelight Software Limited) declined by New Zealand’s Commerce Commission.
Upvote Downvote

 
A2 Milk shines, Fletcher disappoints in earnings season

2018-03-01 nzherald.co.nz
A2 Milk was the standout performer in New Zealand's latest earnings season, posting a jump in profit and a new partnership that went some way to justifying its stratospheric shares.
Upvote Downvote

 
NZ shares mixed; Sky TV, Fletcher fall

2018-02-28 nzherald.co.nz
New Zealand shares were mixed, with Sky Network Television sinking to a ten-week low while Synlait Milk and Trade Me Group gained.
Upvote Downvote

 
MARKET CLOSE: NZ shares mixed; Sky TV, Fletcher fall, Synlait, Trade Me gain

2018-02-28 nbr.co.nz
(BusinessDesk) - New Zealand shares were mixed, with Sky Network Television sinking to a ten-week low while Synlait Milk and Trade Me Group gained.
Upvote Downvote

 
NZ shares dip; Fletcher in trading halt

2018-02-08 nzherald.co.nz
New Zealand shares dipped as heightened global volatility continued to subside, while insurer CBL Corp was suspended pending regulatory investigations and Fletcher Building signalled another profit warning.
Upvote Downvote

 
Air New Zealand leads sharemarket lower

2017-12-18 nzherald.co.nz
New Zealand shares dropped, led lower by Air New Zealand and Contact Energy while Scales Corp and Oceania Healthcare gained.
Upvote Downvote

 
Commerce Commission to appeal High Court decision on price-fixing case

2017-11-24 nzherald.co.nz
The Commerce Commission will file a notice of appeal against the High Court's decision to dismiss its case against two real estate agencies and their directors in a nationwide price fixing case.
Upvote Downvote

 
Fletcher fall drags down market

2017-10-26 nzherald.co.nz
Skellerup advanced 2.3 per cent to $1.76, the highest it has traded since July 2014. Picture / Christine Cornege New Zealand shares fell, dragged lower by Fletcher Building with weakness from Australia & New Zealand Banking Group after its earnings worried investors.
Upvote Downvote

 
NZ shares rise as Restaurant Brands, A2 gain

2017-10-17 nzherald.co.nz
New Zealand shares rose, led by Restaurant Brands and A2 Milk while Xero and Scales Corp fell, with investors still uncertain about the make-up of the next government.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

12h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...